CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病预防

Abstract

Recommended Article

From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older From Focal Lipid Storage to Systemic Inflammation From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient Coronary calcification in the diagnosis of coronary artery disease Mediterranean Diet and the Association Between Air Pollution and Cardiovascular Disease Mortality Risk

Original Research2021 Mar 25;cvab100.

JOURNAL:Cardiovasc Res. Article Link

Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics

DI Swerdlow, DA Rider, A Yavari et al. Keywords: lipoprotein(a)-mediated cardiovascular disease; treatment option; RNA interference therapeutics

Full Text PDF